ATOS
Atossa Therapeutics (ATOS)
$47
About Atossa Therapeutics (ATOS)
Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.
Details
Daily high
$1.48
Daily low
$1.43
Price at open
$1.43
52 Week High
$2.31
52 Week Low
$0.62
Market cap
184.9M
Dividend yield
0.00%
Volume
9,275
Avg. volume
594,301
P/E ratio
-7.12
Atossa Therapeutics News
Details
Daily high
$1.48
Daily low
$1.43
Price at open
$1.43
52 Week High
$2.31
52 Week Low
$0.62
Market cap
184.9M
Dividend yield
0.00%
Volume
9,275
Avg. volume
594,301
P/E ratio
-7.12